Bicillin—a common form of penicillin manufactured by Pfizer and used to treat syphilis—is the newest antibiotic to face a shortage, causing the drugmaker to recommend the use of an alternative, less ...

Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, a long-acting injection of the antibiotic penicillin, the preferred option for treating syphilis during ...

Nov. 30, 2004 — The U.S. Food and Drug Administration (FDA) and King Pharmaceuticals, Inc., have notified healthcare professionals via letter of labeling changes for existing prescribing and route of ...

Pfizer Inc. warned doctors this week of an impending shortage of Bicillin, its long-acting, injectable form of penicillin. The medication is not commonly used for children because alternatives such as ...

The preferred antibiotic treatment for syphilis is in short supply across the United States as infections soar, and more than three dozen leading public health groups are urging the White House to ...

As syphilis cases continue to spike across the U.S. — with some cities and states recently reporting outbreaks — there is a growing concern about the availability of Bicillin, the injectable ...